The Hartford Financial Services Group, Inc. DEB FIX/FLT 42
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 Fundamental Analysis
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (HGH) shows weak financial fundamentals with a PE ratio of 30.28, profit margin of 1.07%, and ROE of 1.68%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 56.5/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze HGH's fundamental strength across five key dimensions:
Efficiency Score
WeakHGH struggles to generate sufficient returns from assets.
Valuation Score
ModerateHGH shows balanced valuation metrics.
Growth Score
WeakHGH faces weak or negative growth trends.
Financial Health Score
ExcellentHGH maintains a strong and stable balance sheet.
Profitability Score
WeakHGH struggles to sustain strong margins.
Key Financial Metrics
Is HGH Expensive or Cheap?
P/E Ratio
HGH trades at 30.28 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, HGH's PEG of -0.33 indicates potential undervaluation.
Price to Book
The market values The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 at 0.37 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -1.97 times EBITDA. This is generally considered low.
How Well Does HGH Make Money?
Net Profit Margin
For every $100 in sales, The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 keeps $1.07 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $1.68 in profit for every $100 of shareholder equity.
ROA
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 generates $0.27 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $20.91 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
30.28
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.33
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.37
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.23
vs 25 benchmark
Current Ratio
Current assets to current liabilities
18.17
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.02
vs 25 benchmark
ROA
Return on assets percentage
0.003
vs 25 benchmark
ROCE
Return on capital employed
0.00
vs 25 benchmark
How HGH Stacks Against Its Sector Peers
| Metric | HGH Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 30.28 | 19.03 | Worse (Expensive) |
| ROE | 1.68% | 818.00% | Weak |
| Net Margin | 1.07% | 1571.00% | Weak |
| Debt/Equity | 0.23 | 0.98 | Strong (Low Leverage) |
| Current Ratio | 18.17 | 669.04 | Strong Liquidity |
| ROA | 0.27% | -21643.00% (disorted) | Weak |
HGH outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews The Hartford Financial Services Group, Inc. DEB FIX/FLT 42's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical